Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.72 - $1.56 $1,281 - $2,776
-1,780 Reduced 2.55%
67,889 $98,000
Q2 2023

Aug 11, 2023

SELL
$1.12 - $1.82 $2,045 - $3,323
-1,826 Reduced 2.55%
69,669 $89,000
Q4 2022

Aug 11, 2023

SELL
$0.67 - $11.9 $2,587 - $45,957
-3,862 Reduced 5.12%
71,495 $107,000
Q4 2022

Feb 13, 2023

SELL
$0.67 - $11.9 $2,587 - $45,957
-3,862 Reduced 5.12%
71,495 $107,000
Q3 2022

Aug 11, 2023

SELL
$1.1 - $12.2 $63 - $707
-58 Reduced 0.08%
75,357 $82,000
Q3 2022

Nov 03, 2022

SELL
$1.1 - $12.2 $63 - $707
-58 Reduced 0.08%
75,357 $89,000
Q1 2022

Aug 11, 2023

BUY
$2.22 - $3.45 $8,702 - $13,524
3,920 Added 5.48%
75,415 $225,000
Q1 2022

May 20, 2022

SELL
$2.22 - $3.45 $46,087 - $71,622
-20,760 Reduced 21.59%
75,415 $225,000
Q4 2021

Feb 16, 2022

BUY
$2.36 - $3.57 $3,719 - $5,626
1,576 Added 1.67%
96,175 $255,000
Q3 2021

Nov 12, 2021

SELL
$3.5 - $4.5 $23,919 - $30,753
-6,834 Reduced 6.74%
94,599 $343,000
Q2 2021

Aug 12, 2021

BUY
$3.09 - $4.54 $1,690 - $2,483
547 Added 0.54%
101,433 $440,000
Q1 2021

May 03, 2021

SELL
$3.35 - $4.93 $15,560 - $22,899
-4,645 Reduced 4.4%
100,886 $345,000
Q4 2020

Feb 12, 2021

BUY
$2.35 - $3.74 $6,582 - $10,475
2,801 Added 2.73%
105,531 $369,000
Q3 2020

Nov 09, 2020

SELL
$1.78 - $4.13 $7,201 - $16,709
-4,046 Reduced 3.79%
102,730 $247,000
Q2 2020

Aug 10, 2020

SELL
$1.41 - $2.05 $5,288 - $7,689
-3,751 Reduced 3.39%
106,776 $192,000
Q1 2020

May 15, 2020

BUY
$1.27 - $3.0 $7,569 - $17,880
5,960 Added 5.7%
110,527 $172,000
Q4 2019

Feb 14, 2020

SELL
$1.6 - $2.43 $10,766 - $16,351
-6,729 Reduced 6.05%
104,567 $224,000
Q2 2019

Aug 14, 2019

SELL
$2.02 - $2.61 $5,252 - $6,786
-2,600 Reduced 2.28%
111,296 $290,000
Q1 2019

May 13, 2019

SELL
$2.0 - $2.65 $12,642 - $16,750
-6,321 Reduced 5.26%
113,896 $293,000
Q4 2018

Feb 14, 2019

BUY
$2.08 - $3.36 $10,709 - $17,300
5,149 Added 4.47%
120,217 $276,000
Q3 2018

Nov 14, 2018

SELL
$2.6 - $3.59 $36,587 - $50,518
-14,072 Reduced 10.9%
115,068 $370,000
Q2 2018

Aug 14, 2018

BUY
$2.83 - $4.11 $47,011 - $68,275
16,612 Added 14.76%
129,140 $366,000
Q1 2018

May 15, 2018

SELL
$3.54 - $4.54 $9,827 - $12,603
-2,776 Reduced 2.41%
112,528 $398,000
Q4 2017

Feb 08, 2018

BUY
$3.23 - $4.3 $44,364 - $59,060
13,735 Added 13.52%
115,304 $447,000
Q3 2017

Nov 14, 2017

BUY
$2.18 - $2.57 $221,420 - $261,032
101,569
101,569 $258,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.